Remove company parexel
article thumbnail

Parexel International’s IT hiring activity declines 3.0% in November 2022

Pharmaceutical Technology

US-based company Parexel International’s IT hiring declined 3.0% The company’s overall hiring activity declined by 9.68% in November 2022 when compared with October 2022. IT jobs claimed a 13.42% share in the company’s total hiring activity in November 2022, and recorded a 1.54% growth over the last three-month average share.

Scientist 130
article thumbnail

Parexel International’s IT hiring activity rises 27.9% in October 2022

Pharmaceutical Technology

US-based company Parexel International’s IT hiring rose 27.9% The company’s overall hiring activity declined by 3.1% share in the company’s total hiring activity in October 2022, and recorded a 0.27% growth over the last three-month average share. Asia-Pacific drives IT hiring at Parexel International.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Parexel International’s IT hiring activity rises 73.6% in August 2022

Pharmaceutical Technology

US-based company Parexel International’s IT hiring rose 73.6% The company’s overall hiring activity increased by 72.59% in August 2022 when compared with July 2022. IT jobs claimed a 13.68% share in the company’s total hiring activity in August 2022, and recorded a 2.3% growth over the last three-month average share.

article thumbnail

Mitigating FSP Talent Shortfalls Through Development

ACRP blog

But as we build current FSP teams, Parexel is moving away from an acquisition-only approach. At Parexel, we’re creating programs for every kind of employee: recent graduates, growth-minded current staff members, and workers from other industries who are ready to change careers. Continuity across the labor force.

article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

Four years after being taken private, Parexel has been sold again, with Goldman Sachs’ private equity arm and EQT paying $8.5 The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added.

article thumbnail

People on the Move: October 2022

Outsourcing Pharma

This monthâs announcements of new hires and appointments include Parexel, Boyds, ACG, and other key companies.

article thumbnail

Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials

BioTech 365

Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials NEW YORK–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company, announced today that Parexel, a leading global … Continue (..)